Tailoring the bioactivities of IL-12 for cancer immunotherapy with mRNA-based technology: from immunocytokines to armored T cell transfer
--
Main Authors: | Di-Trani, C.A. (Claudia Augusta), Berraondo, P. (Pedro), Melero, I. (Ignacio) |
---|---|
Format: | info:eu-repo/semantics/doctoralThesis |
Language: | eng |
Published: |
Universidad de Navarra
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/67876 |
Similar Items
-
Evaluation of Modified Vaccinia virus Ankara based locoregional immunotherapy in peritoneal carcinomatosis models
by: Bella-Carreño, Á. (Ángela), et al.
Published: (2024) -
Towards inmunotherapeutic exploitation strategies of rotumor and antitumor cytokines
by: Olivera, I. (Irene), et al.
Published: (2024) -
Enzyme replacement therapy for acute intermittent porphyria and mRNA-based rescue in a new non-human primate model developed by long-term hepatic expression of iRNA
by: Córdoba, K.M. (Karol M.), et al.
Published: (2023) -
Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis.
by: Gomez, S. (Sara), et al.
Published: (2011) -
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
by: Etxebeste-Mitxeltorena, A. (Amaia), et al.
Published: (2024)